William A. Wexler
CIK: 0001927975
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ERNA
Ernexa Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Wexler William A.
Wexler William A. (SEC CIK 0001927975) files insider reports with the SEC as Director of Ernexa Therapeutics Inc. (ERNA).
Signal8 holds 2 ownership filings by Wexler William A., all Form 4s, filed between Feb 10, 2025 and Sep 1, 2026. Those filings report 2 transactions, from Feb 7, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wexler William A.'s filings is in CAMBRIDGE, MA.
Recent filings by Wexler William A.
Other insiders filing for Ernexa Therapeutics Inc. (ERNA)
- Spiegel Robert J., Director
- Bristol James Arthur, Director
- Cicala Peter, Director
- Polinsky David, Director
- Ratner Elena, Director
- Luther Sanjeev, President and CEO